IP Library › Granted Patent US 12,578,321
Granted Patent B2
US 12,578,321 · App. 18/552,532 · Granted Mar 17, 2026

Polypeptide nanopores synthetically functionalized with positively charged species, and methods of making and using the same

Inventors: Lisa Savagian (San Diego, CA); Burton Simpson (San Diego, CA); Sang Park (San Diego, CA); Boyan Boyanov (San Diego, CA); Jeffrey G. Mandell (Rancho Santa Fe, CA); Seth M. McDonald (San Diego, CA)
Assignee: Illumina, Inc.
G01N33/48721B82B1/008B82B3/0038C12Q1/6869
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,578,321
App. No.
18/552,532
Granted
Mar 17, 2026
Kind
B2
Abstract

Polypeptide nanopores synthetically functionalized with positively charged species, and methods of making and using the same, are provided herein. In some examples, a polypeptide nanopore includes a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue. The mutated amino acid residue may be synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel.

Claims (19)

1 . A polypeptide nanopore comprising a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue which is synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel, wherein the positively charged species has a net charge of +2, wherein the mutated amino acid residue comprises a natural amino acid residue or an unnatural amino acid residue, and wherein the unnatural amino acid residue comprises an alkyne, azide, or alkene.

2 . The polypeptide nanopore of claim 1 , wherein the polypeptide nanopore comprises MspA, Fragaceatoxin C, α-hemolysin, aerolysin, CsgG, or CsgG/CsgF.

3 . The polypeptide nanopore of claim 1 , wherein the polypeptide nanopore comprises multiple polypeptide subunits.

4 . The polypeptide nanopore of claim 1 , comprising a plurality of the positively charged species.

5 . A polypeptide nanopore comprising a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue which is synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel, wherein the polypeptide nanopore comprises MspA, and the mutated amino acid residue is located at residue 90 , 91 , or 93 .

6 . The polypeptide nanopore of claim 5 , wherein the positively charged species comprises a nonmetal cation.

7 . The polypeptide nanopore of claim 5 , wherein the nonmetal cation comprises NR 4 +, where each R group independently comprises hydrogen, a saturated alkyl group, an unsaturated alkyl group, an aromatic species, oxygen, nitrogen, silicon, sulfur, boron, phosphorous, a thiol, an ester derivation, an amide derivation, an amine derivation, a carbonyl derivation, a heterocycle, oligo (siloxane), oligo (ethylene oxide), an amino acid, a nucleobase, a reactive handle for further bioconjugation, a photoactive label, a photoactive dye, a redox-active label, or a redox-active dye, and at least one of the R groups is covalently linked to the mutated amino acid residue through at least one bond; or

wherein the nonmetal cation comprises C 5 H 4 R(NR) + , C 3 H 2 R(NH)(NR) + , C 8 H 7 R(NR 2 ) + , C(NR 2 ) 3 + , SR 3 + , PR 4 + , BR 2 + , C 3 R 3 + (cyclopropenium), C 3 R 3 (NR)S + (thiozonium), or C 3 R 3 (NR)O + (oxazonium), and where each R group independently comprises hydrogen, a saturated alkyl group, an unsaturated alkyl group, an aromatic species, oxygen, nitrogen, silicon, sulfur, boron, phosphorous, a thiol, an ester derivation, an amide derivation, an amine derivation, a carbonyl derivation, a heterocycle, oligo (siloxane), oligo (ethylene oxide), an amino acid, a nucleobase, a reactive handle for further bioconjugation, a photoactive label, a photoactive dye, a redox-active label, a redox-active dye, a nitrogenous aromatic and pi-conjugated species, apyridinium, an imidazolium, an indolium, a guanidinium, a carbazolium, a quinolinium, a functionalized derivative of a pyridinium, or a functionalized derivative of a purinium, and at least one of the R groups is covalently linked to the mutated amino acid residue through at least one bond.

8 . A polypeptide nanopore comprising a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue which is synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel, wherein the positively charged species comprises a cationic metal coordination complex.

9 . The polypeptide nanopore of claim 8 , wherein the cationic metal coordination complex comprises at least one metal ion complexed to one or more nonmetal ligands.

10 . The polypeptide nanopore of claim 9 , wherein the at least one metal ion comprises a transition metal cation or a noble metal cation.

11 . The polypeptide nanopore of claim 9 , wherein the at least one of the one or more nonmetal ligands is covalently bound to the mutated amino acid residue.

12 . A polypeptide nanopore comprising a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue which is synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel, wherein the positively charged species comprises an ionophore.

13 . The polypeptide nanopore of claim 12 , wherein the ionophore is covalently bound to the mutated amino acid residue.

14 . A polypeptide nanopore comprising a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue which is synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel, wherein the polypeptide nanopore comprises multiple polypeptide subunits, and wherein at least one of the multiple polypeptide subunits does not comprise the mutated amino acid residue.

15 . A polypeptide nanopore comprising a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue which is synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel, wherein the polypeptide nanopore comprises multiple polypeptide subunits, and wherein at least two of the polypeptide subunits are cross-linked to one another.

16 . The polypeptide nanopore of claim 15 , wherein the at least two of the polypeptide subunits are crosslinked through the positively charged species.

17 . The polypeptide nanopore of claim 15 , having an overall net charge of between about +2 and +18.

18 . A polypeptide nanopore comprising a first side, a second side, a channel extending through the first and second sides, and a mutated amino acid residue which is synthetically functionalized with a positively charged species that inhibits translocation of cations through the channel, wherein the positively charged species has a net charge of +2, wherein the polypeptide nanopore comprises multiple polypeptide subunits, and wherein each of the polypeptide subunits is coupled to a respective positively charged species.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2024
From: SAVAGIAN, LISA; SIMPSON, BURTON; PARK, SANG; BOYANOV, BOYAN; MANDELL, JEFFREY G.; MCDONALD, SETH M.
To: ILLUMINA, INC.
Reel/Frame 066791/0642 →
Continuity (3)
Continuation In Part PCTUS2022018371 · Mar 1, 2022
Provisional Application 63168646 · Mar 31, 2021
Related Publication 20240280557A1 · Aug 22, 2024
References Cited (61)
US 5795782A · Church et al. · 1998 [cited by applicant]
US 7939249B2 · Parthasarathy et al. · 2011 [cited by applicant]
US 8324360B2 · Kokoris et al. · 2012 [cited by applicant]
US 8349565B2 · Kokoris et al. · 2013 [cited by applicant]
US 8586301B2 · Kokoris et al. · 2013 [cited by applicant]
US 8592182B2 · Kokoris et al. · 2013 [cited by applicant]
US 9670526B2 · Kokoris et al. · 2017 [cited by applicant]
US 9708655B2 · Mandell et al. · 2017 [cited by applicant]
US 9771614B2 · Kokoris et al. · 2017 [cited by applicant]
US 9920386B2 · Kokoris et al. · 2018 [cited by applicant]
US 10301345B2 · Kokoris et al. · 2019 [cited by applicant]
US 10457979B2 · McRuer et al. · 2019 [cited by applicant]
US 10676782B2 · McRuer et al. · 2020 [cited by applicant]
US 10745685B2 · Kokoris et al. · 2020 [cited by applicant]
US 10774105B2 · Kokoris et al. · 2020 [cited by applicant]
US 10851405B2 · Kokoris et al. · 2020 [cited by applicant]
US 10866230B2 · Grinstaff et al. · 2020 [cited by applicant]
US 20100099198A1 · Zhao et al. · 2010 [cited by applicant]
US 20170369944A1 · Barrall et al. · 2017 [cited by applicant]
US 20180364214A1 · Maglia · 2018 [cited by examiner]
US 20200132664A1 · Boyanov et al. · 2020 [cited by applicant]
US 20210263011A1 · Meller et al. · 2021 [cited by applicant]
WO 2005105272A1 · 2005 [cited by applicant]
WO 2012138357A1 · 2012 [cited by applicant]
WO 2013153359A1 · 2013 [cited by applicant]
WO 2014022365A1 · 2014 [cited by applicant]
WO 2016187519A1 · 2016 [cited by applicant]
WO 2018236906A2 · 2018 [cited by applicant]
WO 2019160925A1 · 2019 [cited by applicant]
WO 2020068400A2 · 2020 [cited by applicant]
WO 2020247472A1 · 2020 [cited by applicant]
Y. Astier, et al. “Toward Single Molecule DNA Sequencing: Direct Identification of Ribonucleoside and Deoxyribonucleoside 5′-Monophosphates by Using an Engineered Protein Nanopore Equipped with a Molecular Adapter”, Jou… [cited by examiner]
S. Borsley, et al. “In Situ Synthetic Functionalization of a Transmembrane Protein Nanopore”, ACS Nano, 12: p. 786-794 (Year: 2018). [cited by examiner]
M.M. Haugland, et al. “Synthetically Diversified Protein Nanopores: Resolving Click Reaction Mechanisms”, ACS Nano, 13: p. 4104-4110 (Year: 2019). [cited by examiner]
An et al., “Crown ether-electrolyte interactions permit nanopore detection of individual DNA abasic sites in single molecules,” Proceedings of the National Academy of Sciences (PNAS) 109(29): pp. 11504-11509 (2012). [cited by applicant]
Besanceney-Webler et al., “Increasing the Efficacy of Bioorthogonal Click Reactions for Bioconjugation: A Comparative Study,” Angewandte Chemie—International Edition 50(35): pp. 8051-8056 (2011). [cited by applicant]
Besanceney-Webler et al., “Increasing the Efficacy of Bioorthogonal Click Reactions for Bioconjugation: A Comparative Study,” Angewandte Chemie—International Edition 50(35): pp. 8051-8056 (2011) Supplemental Information. [cited by applicant]
Butler et al., “Single-molecule DNA detection with an engineered MspA protein nanopore,” Proc. Natl. Acad. Sci., 105(52): pp. 20647-20652 (2008). [cited by applicant]
Cao et al., “Discrimination of oligonucleotides of different lengths with a wild-type aerolysin nanopore,” Nature Nanotechnology 11: 713-718 (2016). [cited by applicant]
Cao et al., “Discrimination of oligonucleotides of different lengths with a wild-type aerolysin nanopore,” Nature Nanotechnology 11: 713-718 (2016) Supplemental Information. [cited by applicant]
Cheng et al., “Synthesis of a novel fluorescent ruthenium complex by an appended Ac4GlcNAc moiety by click reaction,” Molecules, 23(7): 1649, 10 pages (2018). [cited by applicant]
Cohen et al.,“An Umpolung Approach for the Chemoselective Arylation of Selenocysteine in Unprotected Peptides,” Journal of the American Chemical Society 137(31): pp. 9784-9787 (2015) DOI: 10.1021/jacs.5b05447. [cited by applicant]
Derrington et al., “Nanopore DNA sequencing with MspA,” Proceedings of the National Academy of Sciences (PNAS) 107(37): pp. 16060-16065 (2010). [cited by applicant]
Griffiths et al., “Site-Selective Modification of Peptides and Proteins via Interception of Free-Radical-Mediated Dechalcogenation,” Angewandte Chemie International 59(52): pp. 23659-23667 (2020). [cited by applicant]
International Search Report and Written Opinion for PCT/US2022/018371 dated May 23, 2022; 12 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US2022/019802 dated Jun. 21, 2022; 12 pages. [cited by applicant]
Jou et al., “Effects of Nanopore Charge Decorations on the Translocation Dynamics of DNA,” Biophysical Journal 113(8): pp. 1664-1672 (2017) XP085222497 DOI: 10.1016/J.BPJ.2017.08.045. [cited by applicant]
Krall et al., “Site-selective protein-modification chemistry for basic biology and drug development,” Nat Chem. 8(2): pp. 103-113 (2016) doi: 10.1038/nchem.2393. [cited by applicant]
Li et al., “Copper-free Sonogashira cross-coupling for functionalization of alkyne-encoded proteins in aqueous medium and in bacterial cells,” J Am Chem Soc. 133(39): pp. 15316-15319 (2011) doi: 10.1021/ja2066913. [cited by applicant]
Maglia et al., “Enhanced translocation of single DNA molecules through alpha-hemolysin nanopores by manipulation of internal charge,” Proceedings of the National Academy of Sciences (PNAS) 105(50): pp. 19720-19725 (2008… [cited by applicant]
Qi et al., “Synergic Effects of the Nanopore Size and Surface Charge on the Ion Selectivity of Graphene Membranes,” J. Phys. Chem. 125(1): pp. 507-514 (2020). [cited by applicant]
Sato et al., “Site-Selective Protein Chemical Modification of Exposed Tyrosine Residues Using Tyrosine Click Reaction,” Bioconjugate Chem. 31(5): pp. 1417-1424 (2020). [cited by applicant]
Sato et al., “Site-Selective Protein Chemical Modification of Exposed Tyrosine Residues Using Tyrosine Click Reaction,” Bioconjugate Chem. 31(5): pp. 1417-1424 (2020) Supplemental Information. [cited by applicant]
Spicer et al., “Selective chemical protein modification,” Nature Communications 5(4740): pp. 1-14 (2014) https://doi.org/10.1038/ncomms5740. [cited by applicant]
Tay et al., “Targeted Activation in Localized Protein Environments via Deep Red Photoredox Catalysis,” ChemRxiv pp. 1-23 (2021) 10.33774/chemrxiv-2021-x9bjv. [cited by applicant]
Van Der Verren et al., “A dual-constriction biological nanopore resolves homonucleotide sequences with high fidelity,” Nature Biotechnology 38(12): pp. 1415.1420 (2020). [cited by applicant]
Vantourout et al., “Serine-Selective Bioconjugation” Journal American Chemistry Society 142(41): pp. 17236-17242 (2020) https://doi.org/10.1021/jacs.0c05595. [cited by applicant]
Vinogradova et al., “Organometallic palladium reagents for cysteine bioconjugation,” Nature 526(7575): pp. 687-691 (2015) doi: 10.1038/nature15739. [cited by applicant]
Wang et al., “Single-molecule DNA detection using a novel SP1 protein nanopore,” Chem. Commun., 49: pp. 1741-1743 (2013). [cited by applicant]
Wang et al., “Single-molecule DNA detection using a novel SP1 protein nanopore,” Chem. Commun., 49: pp. 1741-1743 (2013) Supplemental Information. [cited by applicant]
Wloka et al., “Alpha-helical Fragaceatoxin C nanopore engineered for double-stranded and single-stranded nucleic acid analysis,” Angewandte Chemie Int'l Ed. 55(40): 12494-12498 (2016). [cited by applicant]